• Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
Thursday, November 19, 2026
No Result
View All Result
Subscribe Now
  • Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
    FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

    FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

    Mary Peltola Emerges Victorious in Alaska Senate Race, Making History for Democrats

    Mary Peltola Emerges Victorious in Alaska Senate Race, Making History for Democrats

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Trump Administration Revokes Pay Increase for Head Start Educators

    Trump Administration Revokes Pay Increase for Head Start Educators

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    Beloved Former Los Angeles Times Columnist Steve Harvey Passes Away at 80

    Beloved Former Los Angeles Times Columnist Steve Harvey Passes Away at 80

  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
The Insight Post
  • Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
    FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

    FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

    Mary Peltola Emerges Victorious in Alaska Senate Race, Making History for Democrats

    Mary Peltola Emerges Victorious in Alaska Senate Race, Making History for Democrats

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Trump Administration Revokes Pay Increase for Head Start Educators

    Trump Administration Revokes Pay Increase for Head Start Educators

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    Beloved Former Los Angeles Times Columnist Steve Harvey Passes Away at 80

    Beloved Former Los Angeles Times Columnist Steve Harvey Passes Away at 80

  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
No Result
View All Result
No Result
View All Result
Home Science

Engineered Virus Steals Proteins From H.I.V., Pointing to New Therapy

by Theinsightpost
August 8, 2024
in Science
0 0
0
Engineered Virus Steals Proteins From H.I.V., Pointing to New Therapy

Scientists have developed a new weapon against H.I.V.: a molecular mimic that invades a cell and steals essential proteins from the virus.

A study published in Science on Thursday reported that this viral thief prevented H.I.V. from multiplying inside of monkeys.

The new therapeutic approach will soon be tested in people, the scientists said. Four or five volunteers with H.I.V. will receive a single injection of the engineered virus. “This is imminent,” said Leor Weinberger, a virologist at the University of California, San Francisco, who led the new study.

In a normal H.I.V. infection, the virus slips into an immune cell and hijacks its host’s DNA to make copies of itself, which then burst out of the cell. After a large number of cells have been infected, the immune system collapses, causing AIDS.

For decades, scientists have developed drugs for H.I.V. that attack the virus itself. Some drugs, for example, prevent a protein called a protease from activating H.I.V. And a drug called lenacapavir blocks the proteins that form the virus’s shell. Last week, researchers reported that they could keep the virus at low levels by injecting lenacapavir into volunteers once every six months.

Twenty years ago, Dr. Weinberger set out to try an entirely different approach: creating an impostor virus that interfered with H.I.V.’s normal life cycle.

“I was worried that people would just dismiss me as a wacko, which was not completely unwarranted,” Dr. Weinberger recalled.

Over years, Dr. Weinberger and his colleagues created what they now call therapeutic interfering particles, or TIPs, which have about half of the genetic material of normal H.I.V.

Dr. Weinberger and his colleagues discovered that their TIPs could infect human immune cells in a petri dish and insert their genes into DNA. But they couldn’t get the cells to produce new viruses.

If H.I.V. particles were added to a TIP-infected cell, however, TIP could replicate. The cell also made protein shells — some filled with H.I.V. genes, and others filled with TIP genes.

Dr. Weinberger and his colleagues engineered the TIPs to do a better job of entering the shells. When the infected cells burst open, they released three times more TIPs than H.I.V. viruses.

The researchers predicted that this advantage should allow TIPs to quickly reduce H.I.V. to very low levels. To test their hypothesis, they ran an experiment on monkeys.

The scientists infected the monkeys with a primate version of H.I.V. that normally kills the animals in a matter of weeks. They then gave the animals a single injection of TIPs.

As they predicted, the treatment drove down the level of the virus by a factor of 10,000. Almost all of the monkeys that received the TIPs survived, showing no sign of AIDS. “They looked healthy in any way we could check,” Dr. Weinberger said.

Based on these promising results, Dr. Weinberger and his colleagues have been moving toward testing the experimental treatment in people. They have recruited volunteers infected with H.I.V. who are also terminally ill with cancer and other diseases.

They plan to give the volunteers a single injection of TIPs. If the volunteers fare well, Dr. Weinberg’s team will expand the trial to H.I.V.-infected volunteers who are not terminally ill. They predict that TIPs will drive down their H.I.V. count, as it did in monkeys, he said.

Dr. Weinberger hopes that if TIPs make it through clinical trials, they can be used to offer more protection against AIDS in poor countries. Daily doses of protease inhibitors are too expensive for most people with H.I.V. to rely on. And while lenacapavir may be more effective, it may also be difficult to ensure that people keep up with twice-yearly shots.

Dr. Weinberger’s new study suggests that just one shot of TIPs may keep H.I.V. at low levels — permanently. Not only would this treatment hold off the development of AIDS, but it might make it harder for people to transmit H.I.V. to others.

Asher Leeks, a virologist at Yale University who was not involved in the research, said that it represented a big step forward in the study of so-called cheating viruses. Researchers have been investigating them for decades, but only in recent years have scientists like Dr. Weinberger tried turning them into medical treatments.

Dr. Leeks said that other viruses might also be vulnerable to the same strategy. “In principle, it’s a universal approach to developing antivirals,” he said.

But treatments based on cheating viruses would also raise new ethical questions, said Ben tenOever, a virologist at New York University. Dr. Weinberger’s TIPs inserts themselves into the DNA of a patient’s immune cells. As a result, it becomes a permanent part of their bodies. If they turn out to have unexpected side effects, it may not be possible to remove them.

It’s also conceivable that people with TIPs can spread them to others. If doctors obtain consent from patients to treat them with TIPs, they cannot receive consent from anyone else who is infected with them.

“As the data clearly shows, the H.I.V. TIP works,” Dr. tenOever said. “I am just not sure the world is ready for it.”

ShareTweetSend
Previous Post

Russia-Ukraine war: List of key events, day 896 | Russia-Ukraine war News

Next Post

Will the New Cybercrime Treaty be Used as a Tool for Government Repression? — Global Issues

Related News

Discover the Fascinating Secrets of NASA’s Voyager Mission: Test Your Knowledge!
Science

Discover the Fascinating Secrets of NASA’s Voyager Mission: Test Your Knowledge!

November 19, 2026
Groundbreaking Electric Comb Promises Hair Regrowth in Mice Within Four Weeks, Paving the Way for Future Hair-Loss Solutions
Science

Groundbreaking Electric Comb Promises Hair Regrowth in Mice Within Four Weeks, Paving the Way for Future Hair-Loss Solutions

November 18, 2026
Miniature LSD Doses Administered in Rapid Succession Show Antidepressant Potential in Mice: Exploring the Impact of Timing vs. Tolerance
Science

Miniature LSD Doses Administered in Rapid Succession Show Antidepressant Potential in Mice: Exploring the Impact of Timing vs. Tolerance

November 14, 2026
Investigation Underway: Experts Seek Answers Behind Sudden Brooklyn Building Collapse
Science

Investigation Underway: Experts Seek Answers Behind Sudden Brooklyn Building Collapse

November 12, 2026
Next Post
Will the New Cybercrime Treaty be Used as a Tool for Government Repression? — Global Issues

Will the New Cybercrime Treaty be Used as a Tool for Government Repression? — Global Issues

Discussion about this post

Subscribe To Our Newsletters

    Customer Support


    1251 Wilcrest Drive
    Houston, Texas
    77042 USA
    Call-832.795.1420
    e-mail – news@theinsightpost.com

    Subscribe To Our Newsletters

      Categories

      • Africa
      • Africa-East
      • African Sports
      • American Sports
      • Arts
      • Asia
      • Australia
      • Business
      • Business Asia
      • Business- Africa
      • Canada
      • Defense
      • Education
      • Egypt
      • Energy
      • Entertainment
      • Europe
      • European Soccer
      • Finance
      • Germany
      • Ghana
      • Health
      • Insight
      • International
      • Investing
      • Japan
      • Latest Headlines
      • Life & Living
      • Markets
      • Mobile
      • Movies
      • New Zealand
      • Nigeria
      • Politics
      • Scholarships
      • Science
      • South Africa
      • South America
      • Sports
      • Tech
      • Travel
      • Travel-Africa
      • UK
      • USA
      • Weather
      • World
      No Result
      View All Result

      Recent News

      Anthropic Set to Make Market Debut Today Following Historic  Billion IPO

      Anthropic Set to Make Market Debut Today Following Historic $81 Billion IPO

      November 19, 2026
      Discover the Fascinating Secrets of NASA’s Voyager Mission: Test Your Knowledge!

      Discover the Fascinating Secrets of NASA’s Voyager Mission: Test Your Knowledge!

      November 19, 2026
      WNBA Begins Search for New Commissioner as Cathy Engelbert’s Tenure May Extend to 2027

      WNBA Begins Search for New Commissioner as Cathy Engelbert’s Tenure May Extend to 2027

      November 19, 2026
      Six Drainage Enhancement Projects Pending Financial Approval, Says Ahmed Ibrahim

      Six Drainage Enhancement Projects Pending Financial Approval, Says Ahmed Ibrahim

      November 19, 2026
      • Home
      • Advertise With Us
      • About Us
      • Corporate
      • Consumer Rewards
      • Forum
      • Privacy Policy
      • Social Trends

      Theinsightpost ©2026 | All Rights Reserved. Theinsightpost is an Elnegy LLC company, registered in Texas, USA

      Welcome Back!

      Login to your account below

      Forgotten Password?

      Retrieve your password

      Please enter your username or email address to reset your password.

      Log In

      Add New Playlist

      We are using cookies to give you the best experience on our website.

      You can find out more about which cookies we are using or switch them off in .

      No Result
      View All Result
      • Home
      • Insight
      • Blog
      • Business
      • Entertainment
      • Health
      • Politics
      • Shop
        • Gift Shop
        • Value Shop
        • Store
        • Bargain Shop
        • Discount
      • Sports
      • Tech
      • Travel
      • USA
      • Video
      • World
        • Asia
        • Africa
        • South America
        • North America
        • Europe
        • Oceania

      Theinsightpost ©2026 | All Rights Reserved. Theinsightpost is an Elnegy LLC company, registered in Texas, USA

      The Insight Post
      Powered by  GDPR Cookie Compliance
      Privacy Overview

      This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

      Strictly Necessary Cookies

      Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

      Cookie Policy

      More information about our Cookie Policy